Literature DB >> 1701787

Picolinic acid, a catabolite of tryptophan, as the second signal in the activation of IFN-gamma-primed macrophages.

L Varesio1, M Clayton, E Blasi, R Ruffman, D Radzioch.   

Abstract

We have studied the effects of picolinic acid, a product of tryptophan degradation, on the activation of mouse peritoneal macrophages (M phi). Picolinic acid acts synergistically with IFN-gamma in activating M phi from C57BL/6 mice. Moreover, M phi from C3H/HeJ mice and C3H/HeN that do not become cytotoxic in response to IFN-gamma alone could be fully activated by exposure to picolinate plus IFN-gamma. These results indicate that picolinic acid is a potent costimulator of M phi activation that functions as a second signal. Inasmuch as we have previously demonstrated that the activation of cytotoxic M phi correlates with specific changes in ribosomal RNA (rRNA), we investigated whether picolinic acid could modify M phi RNA metabolism. Picolinic acid inhibited the synthesis of total M phi RNA, the accumulation of newly synthesized 28S rRNA, and augmented the steady state levels of rRNA precursors (pre-rRNA). These changes in RNA metabolism were similar to those previously described in murine M phi activated in vitro or in vivo to express tumoricidal activity. These results demonstrate that picolinic acid is a potent, biologic M phi second signal, suggest that the changes in rRNA are causally connected with the expression of tumoricidal activity, and suggest the existance of an autocrine effect mediated by picolinic acid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701787

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

Review 2.  The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies.

Authors:  Hamed Hosseinalizadeh; Mehrdad Mahmoodpour; Ali Akbar Samadani; Mehryar Habibi Roudkenar
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.738

3.  Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans.

Authors:  E Blasi; R Mazzolla; L Pitzurra; R Barluzzi; F Bistoni
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

4.  Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans.

Authors:  E Blasi; R Barluzzi; R Mazzolla; F Bistoni
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Characterization of environmental regulators of Bordetella pertussis.

Authors:  A R Melton; A A Weiss
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system.

Authors:  J R Moffett; M G Espey; M A Namboodiri
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

7.  M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection.

Authors:  Antje Blumenthal; Gayathri Nagalingam; Jennifer H Huch; Lara Walker; Gilles J Guillemin; George A Smythe; Sabine Ehrt; Warwick J Britton; Bernadette M Saunders
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

8.  The physiological action of picolinic Acid in the human brain.

Authors:  R S Grant; S E Coggan; G A Smythe
Journal:  Int J Tryptophan Res       Date:  2009-04-28

9.  Inhibiting Sialidase-Induced TGF-β1 Activation Attenuates Pulmonary Fibrosis in Mice.

Authors:  Tejas R Karhadkar; Thomas D Meek; Richard H Gomer
Journal:  J Pharmacol Exp Ther       Date:  2020-11-03       Impact factor: 4.030

10.  Picolinic acid, a tryptophan oxidation product, does not impact bone mineral density but increases marrow adiposity.

Authors:  Kehong Ding; Meghan E McGee-Lawrence; Helen Kaiser; Anuj K Sharma; Jessica L Pierce; Debra L Irsik; Wendy B Bollag; Jianrui Xu; Qing Zhong; William Hill; Xing-Ming Shi; Sadanand Fulzele; Eileen J Kennedy; Mohammed Elsalanty; Mark W Hamrick; Carlos M Isales
Journal:  Exp Gerontol       Date:  2020-02-20       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.